000 01362 a2200397 4500
005 20250515043909.0
264 0 _c20070208
008 200702s 0 0 eng d
022 _a0091-2700
024 7 _a10.1177/0091270006292987
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aTeigen, Mette Maja B
245 0 0 _aDosing of gentamicin in patients with end-stage renal disease receiving hemodialysis.
_h[electronic resource]
260 _bJournal of clinical pharmacology
_cNov 2006
300 _a1259-67 p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdolescent
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAged, 80 and over
650 0 4 _aAnti-Bacterial Agents
_xadministration & dosage
650 0 4 _aArea Under Curve
650 0 4 _aDrug Administration Schedule
650 0 4 _aFemale
650 0 4 _aGentamicins
_xadministration & dosage
650 0 4 _aHumans
650 0 4 _aKidney Failure, Chronic
_xblood
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aRenal Dialysis
700 1 _aDuffull, Stephen
700 1 _aDang, Lily
700 1 _aJohnson, David W
773 0 _tJournal of clinical pharmacology
_gvol. 46
_gno. 11
_gp. 1259-67
856 4 0 _uhttps://doi.org/10.1177/0091270006292987
_zAvailable from publisher's website
999 _c16626217
_d16626217